Keyphrases
Antibiotic Resistance
11%
Bacterial Pathogens
22%
Bloodstream Infection
22%
Candida Species
11%
Causative Agents
11%
Clinical Presentation
11%
Clinical Prognosis
11%
Current Therapies
11%
Diagnostic Marker
11%
Epidemiology
11%
Escherichia Coli
11%
Fungal Pathogens
22%
Host Factors
11%
Host Susceptibility
11%
Human Studies
11%
Immunomodulation
11%
Klebsiella Pneumoniae (K. pneumoniae)
11%
Life-limiting Conditions
11%
Novel Host
11%
Novel Pathogen
11%
Pathogen Susceptibility
11%
Prognostic Marker
11%
Prognostic Potential
11%
Pseudomonas Aeruginosa (P. aeruginosa)
11%
Research Laboratories
11%
Sepsis
100%
Staphylococcus Aureus
11%
Streptococcus Pyogenes (S. pyogenes)
11%
Therapeutic Target
11%
Virulence Factors
11%
Medicine and Dentistry
Antibiotic Resistance
11%
Bloodstream Infection
22%
Cohort Effect
11%
Diagnosis
11%
Escherichia coli
11%
Host Factor
11%
Host Susceptibility
11%
Human Study
11%
Immunomodulation
11%
In Vitro
11%
Klebsiella pneumoniae
11%
Pathogen
100%
Pseudomonas aeruginosa
11%
Sepsis
100%
Staphylococcus Aureus
11%
Streptococcus pyogenes
11%
Virulence Factor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
11%
Bloodstream Infection
22%
Candida
11%
Escherichia coli
11%
Host Factor
11%
Human Study
11%
Immunomodulation
11%
Infectious Agent
100%
Klebsiella pneumoniae
11%
Pseudomonas aeruginosa
11%
Sepsis
100%
Staphylococcus Aureus
11%
Streptococcus pyogenes
11%
Virulence Factor
11%
Immunology and Microbiology
Antimicrobial Resistance
14%
Candida
14%
Escherichia coli
14%
Host Factor
14%
Host Susceptibility
14%
Immunomodulation
14%
Infectious Agent
100%
Klebsiella pneumoniae
14%
Pseudomonas aeruginosa
14%
Staphylococcus Aureus
14%
Streptococcus pyogenes
14%
Virulence Factor
14%